Tallman MS - Search Results

1

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, Deben G, Bloomfield CD, Gonzalez J, Feusner JH, Gonzalez M, Gallagher R, Miguel JD, Larson RA, Milone G, Paietta E, Rayon C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MA. Tallman MS, et al. Blood. 2010 Dec 16;116(25):5650-9. doi: 10.1182/blood-2010-06-288613. Epub 2010 Sep 21. Blood. 2010. PMID: 20858857 Free PMC article. Clinical Trial.

2

Retinoids in cancer treatment.

Tallman MS, Wiernik PH. Tallman MS, et al. J Clin Pharmacol. 1992 Oct;32(10):868-88. doi: 10.1002/j.1552-4604.1992.tb04633.x. J Clin Pharmacol. 1992. PMID: 1447394 Review.

3

Detection of differentiation in acute promyelocytic leukemia.

Tallman MS, Kwaan HC, Weitzman SA. Tallman MS, et al. Blood. 1991 Oct 1;78(7):1892-3. Blood. 1991. PMID: 1912572 Free article. No abstract available.

4

Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.

Tallman MS, Kopecky KJ, Amos D, Dahlberg S, Hewlett JS, Files JC, Coltman CA, Thomas ED, Appelbaum FR. Tallman MS, et al. J Clin Oncol. 1989 Mar;7(3):326-37. doi: 10.1200/JCO.1989.7.3.326. J Clin Oncol. 1989. PMID: 2645386

5

The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.

Clift RA, Buckner CD, Thomas ED, Kopecky KJ, Appelbaum FR, Tallman M, Storb R, Sanders J, Sullivan K, Banaji M, et al. Clift RA, et al. Bone Marrow Transplant. 1987 Oct;2(3):243-58. Bone Marrow Transplant. 1987. PMID: 3332174

6

Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.

Tallman MS, Appelbaum FR, Amos D, Goldberg RS, Livingston RB, Mortimer J, Weiden PL, Thomas ED. Tallman MS, et al. J Clin Oncol. 1987 Jun;5(6):918-26. doi: 10.1200/JCO.1987.5.6.918. J Clin Oncol. 1987. PMID: 3585446

7

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH. Tallman MS, et al. J Clin Oncol. 1995 Jul;13(7):1557-63. doi: 10.1200/JCO.1995.13.7.1557. J Clin Oncol. 1995. PMID: 7602344 Clinical Trial.

8

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1995 Aug 15;86(4):1540-7. Blood. 1995. PMID: 7632962 Free article.

9

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

10

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.

Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose E, Peterson LC. Tallman MS, et al. Blood. 1996 Sep 15;88(6):1954-9. Blood. 1996. PMID: 8822913 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters